Skip to content
DraconiticResearch
Search Sources API
186,546 studies31 sourcesUpdated 45 min ago
Peer-reviewedCC BY 4.0Nutrients

Microbial Aromatic Amino Acid Metabolism in Cardiometabolic Disease

  • Jiyeon Kim1,2
  • Ina Nemet1,2,3
  1. 1Department of Heart, Blood, and Kidney Research, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH 44106, USA
  2. 2Center for Microbiome & Human Health, Cleveland Clinic Research, Cleveland Clinic, Cleveland, OH 44106, USA
  3. 3Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA
Open at sourceDOICite

Abstract

The gut microbiota generates a diverse array of metabolites that influence host physiology. Among these, products of microbial metabolism of the aromatic amino acids tryptophan, phenylalanine, tyrosine, and histidine have emerged as important components of host-microbiome interactions relevant to cardiometabolic disease. This Review summarizes the microbial pathways, enzymes, and metabolic networks involved in aromatic amino acid metabolism and examines how dietary substrate availability, microbial community composition, microbial enzymatic capacity, host metabolism, and environmental factors influence metabolite production and biological activity. Microbiota-derived metabolites and host-microbial co-metabolites are associated with inflammation, vascular function, thrombosis, metabolic homeostasis, and host signaling pathways. Their biological effects are context-dependent and influenced by microbial pathway activity, host metabolic processing, tissue compartment, disease stage, and substrate availability. We further distinguish evidence derived from human observational studies, experimental metabolite administration, and demonstrated molecular mechanisms. Finally, we discuss strategies to modulate aromatic amino acid metabolism, including dietary interventions, functional foods, probiotics, fecal microbiota transplantation, microbial enzyme inhibitors, and metabolite sequestration approaches. Current evidence supports a framework linking dietary substrates, microbial enzyme activity, host responses, and cardiometabolic phenotypes, while highlighting important opportunities and challenges for developing precision microbiome-based therapeutics.

Related

  1. Integrating host-microbiota metabolic networks: how aromatic amino acids shape immune homeostasis and affect disease progression
    Yanan Zhang, Xinya Zhao, Haoran Wang +4
    Cellular and Molecular ImmunologyPeer-reviewedCC BYFull text6 citedMolecular biology & gene regulationOpenAlex
  2. Ureic clearance granule ameliorates chronic kidney disease by reshaping microbial dysbiosis via modulating bile acid metabolism
    Li-min Liu, Yu Zhang, Jing-Teng Zhou +6
    Chinese MedicinePeer-reviewedCC BYFull text16 citedMolecular biology & gene regulationOpenAlex
  3. KLF15 regulates sulfur amino acid metabolism through Cystathionine gamma-lyase
    Z. Mehrazad Saber, Y. Takeuchi, S. Karkoutly +8
    bioRxivPreprintAll rights reservedFull textMolecular biology & gene regulationbioRxiv
  4. Microbial production of amino acids from tomato processing waste and techno-economic evaluation
    Mohamed S. Mohamed, Mohamed O. Abdel Fatah, Sodaf A. Maan
    Scientific ReportsPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossref
  5. Psychosocial stress is associated with lipidomic gut microbial and brain connectivity differences relevant to cardiometabolic vulnerability
    Gabriel A. Vignolle, Tien S. Dong, Daniel R. Wang +6
    Scientific ReportsPeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossref

Cite

BibTeXRIS
BibTeX
@article{kim2026microbial,
  title = {{Microbial Aromatic Amino Acid Metabolism in Cardiometabolic Disease}},
  author = {Jiyeon Kim and Ina Nemet},
  journal = {Nutrients},
  year = {2026},
  month = oct,
  doi = {10.3390/nu18213563},
  url = {https://www.mdpi.com/2072-6643/18/21/3563},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Microbial Aromatic Amino Acid Metabolism in Cardiometabolic Disease
AU  - Jiyeon Kim
AU  - Ina Nemet
PY  - 2026
DA  - 2026/10/28
JO  - Nutrients
DO  - 10.3390/nu18213563
UR  - https://www.mdpi.com/2072-6643/18/21/3563
AB  - The gut microbiota generates a diverse array of metabolites that influence host physiology. Among these, products of microbial metabolism of the aromatic amino acids tryptophan, phenylalanine, tyrosine, and histidine have emerged as important components of host-microbiome interactions relevant to cardiometabolic disease. This Review summarizes the microbial pathways, enzymes, and metabolic networks involved in aromatic amino acid metabolism and examines how dietary substrate availability, microbial community composition, microbial enzymatic capacity, host metabolism, and environmental factors influence metabolite production and biological activity. Microbiota-derived metabolites and host-microbial co-metabolites are associated with inflammation, vascular function, thrombosis, metabolic homeostasis, and host signaling pathways. Their biological effects are context-dependent and influenced by microbial pathway activity, host metabolic processing, tissue compartment, disease stage, and substrate availability. We further distinguish evidence derived from human observational studies, experimental metabolite administration, and demonstrated molecular mechanisms. Finally, we discuss strategies to modulate aromatic amino acid metabolism, including dietary interventions, functional foods, probiotics, fecal microbiota transplantation, microbial enzyme inhibitors, and metabolite sequestration approaches. Current evidence supports a framework linking dietary substrates, microbial enzyme activity, host responses, and cardiometabolic phenotypes, while highlighting important opportunities and challenges for developing precision microbiome-based therapeutics.
SN  - 2072-6643
ER  -